Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
53.52 USD | -0.43% |
|
-0.98% | -3.66% |
14/06 | Arcellx Insider Sold Shares Worth $1,102,668, According to a Recent SEC Filing | MT |
31/05 | Piper Sandler Starts Arcellx With Overweight Rating, $70 Price Target | MT |
Business Summary
Number of employees: 130
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Cell Therapies
100.0
%
| 0 | nan % | 110 | 100.0 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | nan % | 110 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Rami Elghandour
CEO | Chief Executive Officer | 45 | 22/21/22 |
Michelle Gilson
DFI | Director of Finance/CFO | 32 | 23/22/23 |
David Tice
CTO | Chief Tech/Sci/R&D Officer | 53 | 01/20/01 |
Narinder Singh
CTO | Chief Tech/Sci/R&D Officer | 51 | 01/21/01 |
Chief Tech/Sci/R&D Officer | 44 | 01/21/01 | |
Myesha Lacy
IRC | Investor Relations Contact | - | 01/21/01 |
General Counsel | - | 21/22/21 | |
Aileen Fernandes
PRN | Corporate Officer/Principal | - | 01/21/01 |
Kate Aiken
HRO | Human Resources Officer | - | 01/13/01 |
Neeraj Teotia
PRN | Corporate Officer/Principal | 49 | 01/21/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Lubner
BRD | Director/Board Member | 60 | 01/20/01 |
Ali Behbahani
BRD | Director/Board Member | 45 | 01/15/01 |
Rami Elghandour
CEO | Chief Executive Officer | 45 | 22/21/22 |
Jill Carroll
BRD | Director/Board Member | 48 | 01/17/01 |
Kavita Patel
BRD | Director/Board Member | 50 | 01/21/01 |
Derek Yoon
BRD | Director/Board Member | 49 | 01/20/01 |
Olivia Ware
BRD | Director/Board Member | 67 | 16/22/16 |
Hong Xia Wang
BRD | Director/Board Member | 48 | 01/21/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 53,502,572 | 42,703,096 ( 79.82 %) | 0 | 79.82 % |
Company contact information
![address Arcellx, Inc.(ACLX)](https://cdn.zonebourse.com/static/address/132884730.png)
Sector
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.66% | 287.58Cr | |
+35.19% | 5.28TCr | |
-7.46% | 3.89TCr | |
+35.45% | 3.82TCr | |
-10.77% | 2.68TCr | |
+11.82% | 2.62TCr | |
-18.70% | 1.99TCr | |
+35.75% | 1.32TCr | |
+29.36% | 1.22TCr | |
-3.03% | 1.18TCr |
- Stock Market
- Equities
- ACLX Stock
- Company Arcellx, Inc.